FANCD2 - FA complementation group D2 Gene
Also Known as FA4; FAD; FACD; FAD2; FA-D2; FANCD
Species: Homo sapiens
About FANCD2
This gene has 18 transcripts (splice variants), 194 orthologues and is associated with 101 phenotypes. Broad expression in testis (RPKM 7.7), bone marrow (RPKM 6.2) and 20 other tissues.
Summary
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with Other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
FANCD2 Products (6)
| mRNA | Protein | Name |
|---|---|---|
| NM_001018115.3 | NP_001018125.1 | Fanconi anemia group D2 protein isoform b |
| NM_001319984.2 | NP_001306913.1 | Fanconi anemia group D2 protein isoform b |
| NM_001374253.1 | NP_001361182.1 | Fanconi anemia group D2 protein isoform c |
| NM_001374254.1 | NP_001361183.1 | Fanconi anemia group D2 protein isoform d |
| NM_001374255.1 | NP_001361184.1 | Fanconi anemia group D2 protein isoform e |
| NM_033084.6 | NP_149075.2 | Fanconi anemia group D2 protein isoform a |
| Molecular Function GO Annotation | Evidence | Referencias | Source |
|---|---|---|---|
| enables DNA polymerase binding |
IPI
IPI: Inferred from physical interaction
|
19995904 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
12874027 | GOA |
| Biological Process GO Annotation | Evidence | Referencias | Source |
|---|---|---|---|
| involved in response to gamma radiation |
IDA
IDA: Inferred from direct assay
|
12874027 | GOA |
| Cellular Component GO Annotation | Evidence | Referencias | Source |
|---|---|---|---|
| part of DNA repair complex |
IPI
IPI: Inferred from physical interaction
|
32269332 | GOA |
| located in nucleus |
IDA
IDA: Inferred from direct assay
|
26323318 | GOA |
FANCD2 Protein Structure
FancD2: Fanconi anaemia protein FancD2 nuclease (1 - 1424)
- 0
- 300
- 600
- 900
- 1200
- 1451 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
Fanconi anemia group D2 protein |
|
FANCD2 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | Referencias |
|---|---|---|---|---|---|---|---|
|
Intra
|
FANCD2 | Q9BXW9 | FANCI | Homo sapiens | Q9NVI1 | 20603015 | |
|
Intra
|
FANCD2 | Q9BXW9 | FSCN1 | Homo sapiens | Q16658 | 20603015 | |
|
Intra
|
FANCD2 | Q9BXW9 | MRE11 | Homo sapiens | P49959 | 19609304 | |
|
Intra
|
FANCD2 | Q9BXW9 | MRE11 | Homo sapiens | P49959 | 19609304 | |
|
Intra
|
FANCD2 | Q9BXW9 | MRE11 | Homo sapiens | P49959 | 19609304 | |
|
Intra
|
FANCD2 | Q9BXW9 | MRE11 | Homo sapiens | P49959 | 19609304 | |
|
Intra
|
FANCD2 | Q9BXW9 | NBN | Homo sapiens | O60934 | 19609304 | |
|
Intra
|
FANCD2 | Q9BXW9 | NBN | Homo sapiens | O60934 | 19609304 | |
|
Intra
|
FANCD2 | Q9BXW9 | NBN | Homo sapiens | O60934 | 19609304 | |
|
Intra
|
FANCD2 | Q9BXW9 | NBN | Homo sapiens | O60934 | 19609304 | |
|
Intra
|
FANCD2 | Q9BXW9 | MEN1 | Homo sapiens | O00255 | 12874027 | |
|
Intra
|
FANCD2 | Q9BXW9 | CEBPD | Homo sapiens | P49716 | 20805509 | |
|
Intra
|
FANCD2 | Q9BXW9 | BRCA2 | Homo sapiens | P51587 | 18212739 | |
|
Intra
|
FANCD2 | Q9BXW9 | BRCA2 | Homo sapiens | P51587 | 15115758 |
FANCD2 Antibodies
| Referencia número | Nombre del producto | Aplicación | Reactivity |
|---|---|---|---|
| HY-P83357 | FANCD2 Antibody (YA3102) | WB, IHC-P, ICC/IF, IP | Human, Mouse, Rat |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Fanconi Anemia, Complementation Group D2 |
|
|
| Fanconi Anemia, Complementation Group A |
|
|
| Erythrocytosis, Familial, 2 |
|
|
| Von Hippel-Lindau Syndrome |
|
|
| Fanconi Anemia, Complementation Group F |
|
|
| Fanconi Anemia, Complementation Group E |
|
|
| Fanconi Anemia, Complementation Group B |
|
|
| Fanconi Anemia, Complementation Group D1 |
|
|
| Fanconi Anemia, Complementation Group I |
|
|
| Ataxia-Telangiectasia |
|
|
| Nijmegen Breakage Syndrome |
|
|
| Physical Disorder |
|
|
| Interstitial Nephritis, Karyomegalic |
|
|
| Deficiency Anemia |
|
|
| Fanconi Anemia, Complementation Group T |
|
|
| Fanconi Anemia, Complementation Group G |
|
|
| Cutis Laxa, Autosomal Dominant 1 |
|
|
| Orbit Embryonal Rhabdomyosarcoma |
|
|
| Fanconi Anemia, Complementation Group J |
|
|
| Xeroderma Pigmentosum, Variant Type |
|
|
| Xeroderma Pigmentosum, Complementation Group F |
|
|
| Fanconi Anemia, Complementation Group C |
|
|
| Aneurysm, Intracranial Berry, 12 |
|
|
| Sporadic Breast Cancer |
|
|
| Breast Cancer |
|
|
| Aplastic Anemia |
|
|
| Orbit Rhabdomyosarcoma |
|
|
| Myelodysplastic Syndrome |
|
|
| Seckel Syndrome |
|
|
| Chronic Fatigue Syndrome |
|
|
| Ovarian Cancer |
|
|
| Squamous Cell Carcinoma, Head And Neck |
|
|
| Hereditary Breast Ovarian Cancer Syndrome |
|
|
| Dyskeratosis Congenita |
|
|
| Lynch Syndrome |
|
|
| Diamond-Blackfan Anemia |
|
|
| Congenital Nervous System Abnormality |
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Mus musculus | FANCD2 | MGD | MGI:2448480 |
| Bos taurus | FANCD2 | VGNC | VGNC:28855 |
| Rattus norvegicus | FANCD2 | RGD | RGD:1303172 |
| Canis familiaris | FANCD2 | VGNC | VGNC:40719 |
| Felis catus | FANCD2 | VGNC | VGNC:62142 |
| Others | FANCD2 | NCBI |